GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Apyx Medical Corp (FRA:BOV) » Definitions » Cyclically Adjusted PS Ratio

Apyx Medical (FRA:BOV) Cyclically Adjusted PS Ratio : 1.23 (As of Jun. 18, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Apyx Medical Cyclically Adjusted PS Ratio?

As of today (2024-06-18), Apyx Medical's current share price is €1.30. Apyx Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €1.06. Apyx Medical's Cyclically Adjusted PS Ratio for today is 1.23.

The historical rank and industry rank for Apyx Medical's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:BOV' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.02   Med: 2.66   Max: 14.58
Current: 1.23

During the past years, Apyx Medical's highest Cyclically Adjusted PS Ratio was 14.58. The lowest was 1.02. And the median was 2.66.

FRA:BOV's Cyclically Adjusted PS Ratio is ranked better than
66.46% of 477 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs FRA:BOV: 1.23

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Apyx Medical's adjusted revenue per share data for the three months ended in Mar. 2024 was €0.272. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €1.06 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Apyx Medical Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Apyx Medical's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apyx Medical Cyclically Adjusted PS Ratio Chart

Apyx Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.11 6.41 10.96 1.99 2.20

Apyx Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.42 4.21 2.67 2.20 1.14

Competitive Comparison of Apyx Medical's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Apyx Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apyx Medical's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Apyx Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Apyx Medical's Cyclically Adjusted PS Ratio falls into.



Apyx Medical Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Apyx Medical's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1.30/1.06
=1.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apyx Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Apyx Medical's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.272/131.7762*131.7762
=0.272

Current CPI (Mar. 2024) = 131.7762.

Apyx Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.241 100.560 0.316
201409 0.296 100.428 0.388
201412 0.339 99.070 0.451
201503 0.277 99.621 0.366
201506 0.265 100.684 0.347
201509 0.258 100.392 0.339
201512 0.238 99.792 0.314
201603 0.258 100.470 0.338
201606 0.306 101.688 0.397
201609 0.331 101.861 0.428
201612 -0.607 101.863 -0.785
201703 0.254 102.862 0.325
201706 0.283 103.349 0.361
201709 0.072 104.136 0.091
201712 0.094 104.011 0.119
201803 0.084 105.290 0.105
201806 0.116 106.317 0.144
201809 0.090 106.507 0.111
201812 0.144 105.998 0.179
201903 0.149 107.251 0.183
201906 0.176 108.070 0.215
201909 0.202 108.329 0.246
201912 0.221 108.420 0.269
202003 0.132 108.902 0.160
202006 0.112 108.767 0.136
202009 0.173 109.815 0.208
202012 0.275 109.897 0.330
202103 0.212 111.754 0.250
202106 0.271 114.631 0.312
202109 0.293 115.734 0.334
202112 0.433 117.630 0.485
202203 0.329 121.301 0.357
202206 0.282 125.017 0.297
202209 0.266 125.227 0.280
202212 0.344 125.222 0.362
202303 0.328 127.348 0.339
202306 0.362 128.729 0.371
202309 0.324 129.860 0.329
202312 0.388 129.419 0.395
202403 0.272 131.776 0.272

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Apyx Medical  (FRA:BOV) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Apyx Medical Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Apyx Medical's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Apyx Medical (FRA:BOV) Business Description

Traded in Other Exchanges
Address
5115 Ulmerton Road, Clearwater, FL, USA, 33760
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Apyx Medical (FRA:BOV) Headlines

No Headlines